About Us

News you need — Rheumatology News, an independent newspaper published 12 times a year for rheumatologists and other physicians treating rheumatologic conditions, informs its readers about clinical developments that will impact the care of patients. Early alerts on the latest studies in rheumatoid arthritis, osteoarthritis, and musculoskeletal and immune-mediated disorders are delivered by skilled reporters who attend medical meetings, monitor the deliberations of the Food and Drug Administration advisory committees, and talk with the thought-leaders in patient care. For thousands of specialists, Rheumatology News is a must-read.

Our Mission
Rheumatology News Digital Network provides medical specialty news coverage tailored to the needs and interests of practicing rheumatologists. Our staff of medical journalists strives to provide news that is fair, balanced and accurate. We adhere to policies of fact verification and disclosures of interest by sources quoted in our articles. We encourage a lively forum of perspectives and opinions from our online communities. We seek to inform, engage, educate, and entertain in an environment of transparency and full disclosure. To accomplish these goals, we rely on our editorial advisory board, our staff and our most important partners, our readers.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical, and medical information products and services. Working in partnership with the global science and health communities, Elsevier’s 7000 employees in over 70 offices worldwide publish more than 2000 journals and 1900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect, MD Consult, Scopus, bibliographic databases, and online reference works.

Elsevier is a global business headquartered in Amsterdam, the Netherlands, and has offices worldwide. Elsevier is part of Reed Elsevier Group plc, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK, and ENL (New York Stock Exchange).

• About Rheumatology News Digital Network
• Editorial Staff
• Editorial Advisory Board
• Contact Us
• Advertise
• Subscription Renew
• Privacy Policy
• Copyright & Terms of Use